Benjamin Edwards Inc. grew its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 802.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,630 shares of the company's stock after buying an additional 4,117 shares during the period. Benjamin Edwards Inc.'s holdings in Cardinal Health were worth $512,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Paloma Partners Management Co acquired a new position in Cardinal Health in the third quarter valued at about $283,000. Kestra Investment Management LLC bought a new stake in shares of Cardinal Health during the 3rd quarter worth approximately $202,000. L.M. Kohn & Company bought a new position in shares of Cardinal Health in the 3rd quarter valued at $216,000. Caisse DE Depot ET Placement DU Quebec raised its holdings in shares of Cardinal Health by 230.0% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock worth $52,819,000 after buying an additional 333,095 shares in the last quarter. Finally, Fred Alger Management LLC boosted its stake in Cardinal Health by 4.7% in the third quarter. Fred Alger Management LLC now owns 31,052 shares of the company's stock valued at $3,432,000 after buying an additional 1,383 shares in the last quarter. Institutional investors own 87.17% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on CAH shares. UBS Group increased their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a report on Monday, November 4th. StockNews.com lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd. Evercore ISI upped their price target on shares of Cardinal Health from $105.00 to $115.00 and gave the stock an "in-line" rating in a report on Thursday, August 15th. Robert W. Baird raised their price objective on Cardinal Health from $130.00 to $137.00 and gave the company an "outperform" rating in a report on Thursday, August 15th. Finally, JPMorgan Chase & Co. increased their target price on Cardinal Health from $111.00 to $123.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $124.58.
View Our Latest Report on CAH
Cardinal Health Price Performance
Shares of Cardinal Health stock traded down $1.15 on Monday, hitting $121.61. 2,087,082 shares of the company's stock traded hands, compared to its average volume of 2,103,639. The company has a market capitalization of $29.43 billion, a price-to-earnings ratio of 23.66, a price-to-earnings-growth ratio of 1.53 and a beta of 0.61. The company has a fifty day moving average of $116.51 and a two-hundred day moving average of $107.90. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $126.23.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. Cardinal Health's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.73 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.66%. Cardinal Health's dividend payout ratio (DPR) is presently 39.30%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.